Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Eur Acad Dermatol Venereol. 2012 Mar;26(3):336–343. doi: 10.1111/j.1468-3083.2011.04071.x

Table 3.

Predictors of cardiovascular disease* in psoriasis

Hazard ratio (95% confidence intervals) for cardiovascular events
Age and sex-adjusted Multivariate adjusted**
Prevalent (vs incident) 1.03 (0.81, 1.31) 1.14 (0.75, 1.73)
Psoriatic arthritis$ 1.28 (0.90, 1.83) 1.21 (0.68, 2.15)
Phototherapy$ 3.76 (2.45, 5.77) 1.28 (0.55, 2.98)
Any systemic therapy$ 2.17 (1.50, 3.13) 0.93 (0.49, 1.75)
*

includes MI, revascularization procedures, cerebrovascular events, HF and cardiovascular death.

**

adjusted for age, sex, obesity, dyslipidemia, hypertension, diabetes mellitus, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, blood pressure values

$

time-dependent covariates

Data presented in this table come from the prevalence cohort